EP Sciences is an early stage company developing a novel method to reduce the severe pain associated with implantable defibrillator shocks. EP Science has received an SBIR Phase IIb grant along with funding from Broadview Ventures.
EP Sciences
EP Sciences is an early stage company developing a novel method to reduce the severe pain associated with implantable defibrillator shocks. EP Science has received an SBIR Phase IIb grant along with funding from Broadview Ventures.